A detailed history of Vise Technologies, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Vise Technologies, Inc. holds 16,705 shares of NVS stock, worth $1.73 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
16,705
Previous 16,365 2.08%
Holding current value
$1.73 Million
Previous $1.74 Million 10.28%
% of portfolio
0.25%
Previous 0.31%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$106.13 - $120.89 $36,084 - $41,102
340 Added 2.08%
16,705 $1.92 Million
Q2 2024

Aug 01, 2024

BUY
$92.57 - $107.37 $63,503 - $73,655
686 Added 4.38%
16,365 $1.74 Million
Q1 2024

May 15, 2024

SELL
$95.27 - $108.47 $61,068 - $69,529
-641 Reduced 3.93%
15,679 $1.52 Million
Q4 2023

Feb 07, 2024

BUY
$92.27 - $101.54 $75,384 - $82,958
817 Added 5.27%
16,320 $1.65 Million
Q3 2023

Oct 31, 2023

SELL
$94.73 - $105.13 $56,743 - $62,972
-599 Reduced 3.72%
15,503 $1.58 Million
Q2 2023

Aug 08, 2023

BUY
$92.52 - $104.91 $150,530 - $170,688
1,627 Added 11.24%
16,102 $1.62 Million
Q1 2023

May 10, 2023

BUY
$80.03 - $92.81 $40,735 - $47,240
509 Added 3.64%
14,475 $1.33 Million
Q4 2022

Feb 09, 2023

BUY
$75.55 - $92.52 $109,698 - $134,339
1,452 Added 11.6%
13,966 $1.27 Million
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $194,732 - $227,748
2,610 Added 26.35%
12,514 $951,000
Q2 2022

Aug 15, 2022

BUY
$80.52 - $93.75 $285,604 - $332,531
3,547 Added 55.8%
9,904 $837,000
Q1 2022

Jun 08, 2022

BUY
$80.11 - $90.62 $308,022 - $348,433
3,845 Added 153.07%
6,357 $558,000
Q4 2021

Jun 07, 2022

BUY
$79.7 - $88.13 $200,206 - $221,382
2,512 New
2,512 $220,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Vise Technologies, Inc. Portfolio

Follow Vise Technologies, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vise Technologies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vise Technologies, Inc. with notifications on news.